GLP-1s Are Not the End of Bariatric Surgery; They’re the Beginning of Better Obesity Care - Poll - MDSpire

GLP-1s Are Not the End of Bariatric Surgery; They’re the Beginning of Better Obesity Care

The premise that GLP-1 receptor agonists are replacing bariatric surgery for weight management is not just oversimplified; it’s wrong.

  • By

  • April 30, 2026

  • 6 min

Share

Original Source(s)

GLP-1s Are Not the End of Bariatric Surgery; They’re the Beginning of Better Obesity Care

  • by

  • April 30, 2026

Related Content

Creation and External Validation of a Predictive Model for Postoperative Hypoxemia Following Laparoscopic Sleeve Gastrectomy in Obese Patients: A Multicenter Retrospective Analysis

Publisher Correction: Machine Learning Models for Predicting Significant Liver Fibrosis in Patients with Severe Obesity and Nonalcoholic Fatty Liver Disease

The Heresy of Hypoabsorptive Bariatric Surgery: A Critical Reappraisal of Long-Term Outcomes and Clinical Trade-Offs